NTLA vs. BRK-B
NTLA (Intellia Therapeutics, Inc.) and BRK-B (Berkshire Hathaway Inc.) are both stocks. NTLA operates in Biotechnology (Healthcare), while BRK-B operates in Insurance - Diversified (Financial Services). Over the past 10 years, NTLA returned -7.62%/yr vs 13.22%/yr for BRK-B. At a 0.21 correlation, their price movements are largely independent.
Performance
NTLA vs. BRK-B - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NTLA achieves a 34.71% return, which is significantly higher than BRK-B's -2.67% return. Over the past 10 years, NTLA has underperformed BRK-B with an annualized return of -7.62%, while BRK-B has yielded a comparatively higher 13.22% annualized return.
NTLA
- 1D
- -1.94%
- 1M
- -7.49%
- YTD
- 34.71%
- 6M
- 34.26%
- 1Y
- 45.73%
- 3Y*
- -35.92%
- 5Y*
- -32.32%
- 10Y*
- -7.62%
BRK-B
- 1D
- 0.71%
- 1M
- 1.36%
- YTD
- -2.67%
- 6M
- -2.06%
- 1Y
- 0.35%
- 3Y*
- 13.30%
- 5Y*
- 11.27%
- 10Y*
- 13.22%
NTLA vs. BRK-B - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NTLA Intellia Therapeutics, Inc. | 34.71% | -22.90% | -61.76% | -12.61% | -70.49% | 117.35% | 270.82% | 7.47% | -28.98% | 46.61% |
BRK-B Berkshire Hathaway Inc. | -2.67% | 10.89% | 27.09% | 15.46% | 3.31% | 28.95% | 2.37% | 10.93% | 3.01% | 21.62% |
Correlation
The correlation between NTLA and BRK-B is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since May 6, 2016 | 0.21 |
The correlation between NTLA and BRK-B shifts across timeframes, from -0.06 (1 year) to 0.21 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
NTLA:
$1.43B
BRK-B:
$1.06T
NTLA:
-$3.58
BRK-B:
$33.62
NTLA:
20.19
BRK-B:
2.81
NTLA:
2.31
BRK-B:
1.45
NTLA:
$66.09M
BRK-B:
$375.39B
NTLA:
-$33.92M
BRK-B:
$94.36B
NTLA:
-$299.32M
BRK-B:
$71.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NTLA vs. BRK-B — Risk / Return Rank
NTLA
BRK-B
NTLA vs. BRK-B - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NTLA | BRK-B | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.48 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.01 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.63 | -0.02 | +0.66 |
| Martin ratioReturn relative to average drawdown | 0.99 | -0.05 | +1.04 |
Loading charts...
Drawdowns
NTLA vs. BRK-B - Drawdown Comparison
The maximum NTLA drawdown since its inception was -96.45%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for NTLA and BRK-B.
Loading charts...
Drawdown Indicators
| NTLA | BRK-B | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.45% | -53.86% | -42.59% |
Max Drawdown (1Y)Largest decline over 1 year | -71.27% | -9.42% | -61.85% |
Max Drawdown (3Y)Largest decline over 3 years | -86.28% | -14.95% | -71.33% |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | -26.58% | -69.87% |
Max Drawdown (10Y)Largest decline over 10 years | -96.45% | -29.57% | -66.88% |
Current DrawdownCurrent decline from peak | -93.15% | -9.36% | -83.79% |
Average DrawdownAverage peak-to-trough decline | -57.11% | -11.07% | -46.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.80% | 4.53% | +41.27% |
Volatility
NTLA vs. BRK-B - Volatility Comparison
Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 24.01% compared to Berkshire Hathaway Inc. (BRK-B) at 3.95%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NTLA | BRK-B | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.01% | 3.95% | +20.06% |
Volatility (6M)Calculated over the trailing 6-month period | 54.68% | 10.78% | +43.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.60% | 14.38% | +82.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.85% | 17.12% | +63.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.41% | 19.44% | +58.97% |
Dividends
NTLA vs. BRK-B - Dividend Comparison
Neither NTLA nor BRK-B has paid dividends to shareholders.
Financials
NTLA vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between Intellia Therapeutics, Inc. and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NTLA and BRK-B have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NTLA has higher volatility (24.01%) compared to BRK-B (3.95%). In terms of maximum drawdown, NTLA dropped -96.45% vs BRK-B's -53.86%.
NTLA currently has the higher Sharpe Ratio (0.47 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NTLA and BRK-B
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer